Actual Medicinal Product (AMP) -
Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd)
Name Details
Current Name
Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pens
|
Start Date
26-02-2020
|
End Date
|
Previous Name
Bydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pen
|
Start Date
12-11-2015
|
End Date
25-02-2020
|
|
Abbreviated Name
Bydureon 2mg inj pre-filled pens
|
Start Date
26-02-2020
|
|
Bydureon 2mg inj pre-filled pen |
Previous Start Date
08-01-2015
|
Previous End Date
25-02-2020
|
Summary
- Licensed Route
- Subcutaneous
- Availability Restrictions
- Not available
- Licensing Authority
- Medicines - MHRA/EMA
Codes
BNF |
Previous BNF
06010203
|
Start Date
04-06-2015
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
28426011000001108 |
08-01-2015 |
|
Actual Medicinal Product Pack (AMPP) Information